| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |